BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7277589)

  • 1. The diagnostic value of urine versus bladder washing in patients with bladder cancer.
    Murphy WM; Crabtree WN; Jukkola AF; Soloway MS
    J Urol; 1981 Sep; 126(3):320-2. PubMed ID: 7277589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
    Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
    J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of urine cytology versus bladder washing in bladder cancer.
    Matzkin H; Moinuddin SM; Soloway MS
    Urology; 1992 Mar; 39(3):201-3. PubMed ID: 1546409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic contribution of bladder washing and multiple biopsies in bladder cancers.
    Denis L; Nowé P; Declercq G
    Eur Urol; 1980; 6(3):137-8. PubMed ID: 7371657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.
    Bubendorf L; Grilli B; Sauter G; Mihatsch MJ; Gasser TC; Dalquen P
    Am J Clin Pathol; 2001 Jul; 116(1):79-86. PubMed ID: 11447756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms.
    Murphy WM; Rivera-Ramirez I; Medina CA; Wright NJ; Wajsman Z
    J Urol; 1997 Dec; 158(6):2102-6. PubMed ID: 9366322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bladder washing cytology for bladder cancer surveillance.
    Flanagan MJ; Miller A
    J Urol; 1978 Jan; 119(1):42-3. PubMed ID: 621812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
    Bergman J; Reznichek RC; Rajfer J
    BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voided urine versus bladder washing cytology for detection of urothelial carcinoma: which is better?
    Keller AK; Jensen JB
    Scand J Urol; 2017 Aug; 51(4):290-292. PubMed ID: 28398114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary cytology and bladder biopsy in patients with bladder cancer.
    Loening S; Fallon B; Narayana A; Penick GD; Hawtrey C; Culp DA; Bonney WW
    Urology; 1978 Jun; 11(6):591-5. PubMed ID: 675925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience.
    Klein FA; White FK
    J Urol; 1988 Feb; 139(2):275-8. PubMed ID: 3339724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of flow cytometry of bladder lavage in the surveillance of bladder tumors].
    Hijazi A; Devonec M; Muchada E; Dubernard JM; Revillard JP
    J Urol (Paris); 1987; 93(1):11-20. PubMed ID: 3559255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the recurrence rate of bladder cancer.
    Loening S; Narayana A; Yoder L; Slymen D; Weinstein S; Penick G; Culp D
    J Urol; 1980 Jan; 123(1):29-31. PubMed ID: 7351716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinically applicable method to preserve urine and bladder washing cells for flow cytometric monitoring of bladder cancer patients.
    Deitch AD; Andreotti VA; Strand MA; Howell L; deVere White RW
    J Urol; 1990 Apr; 143(4):700-5. PubMed ID: 2179581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine: a suitable sample for deoxyribonucleic acid flow cytometry studies in patients with bladder cancer.
    deVere White RW; Deitch AD; Baker WC; Strand MA
    J Urol; 1988 May; 139(5):926-8. PubMed ID: 3361665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quick-staining urinary cytology and bladder wash image analysis with an integrated risk classification: a worthwhile improvement in the follow-up of bladder cancer?
    Wiener HG; Remkes GW; Schatzl G; Susani M; Breitenecker G
    Cancer; 1999 Oct; 87(5):263-9. PubMed ID: 10536351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin.
    Bretton PR; Herr HW; Kimmel M; Fair WR; Whitmore WF; Melamed MR
    J Urol; 1989 Jun; 141(6):1332-6. PubMed ID: 2724430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bladder tumors: superiority of urinary cytology after bladder lavage].
    Boccon-Gibod L; Loridon B; Boccon-Gibod L; Deslignières S
    Ann Urol (Paris); 1985; 19(6):389-91. PubMed ID: 4096512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.